{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:58:10Z","timestamp":1785455890574,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00467-026-07311-9","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T23:30:59Z","timestamp":1776641459000},"page":"3093-3099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and molecular spectrum of primary hyperoxaluria type 1 in Tunisia: pediatric presentation and minimum observed prevalence"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-5536","authenticated-orcid":false,"given":"Ridha","family":"M\u2019rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlem","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Koubaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Bousetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayet","family":"Kaaroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Karim","family":"Zouaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzeddine","family":"Abderrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahar","family":"Gargah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mediha","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"7311_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat P, Rumsby G (2013) Primary hyperoxaluria. N Engl J Med 369:649\u2013658. https:\/\/doi.org\/10.1056\/NEJMra1301564","journal-title":"N Engl J Med"},{"key":"7311_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrneph.2012.113","volume":"8","author":"B Hoppe","year":"2012","unstructured":"Hoppe B (2012) An update on primary hyperoxaluria. Nat Rev Nephrol 8:467\u2013475. https:\/\/doi.org\/10.1038\/nrneph.2012.113","journal-title":"Nat Rev Nephrol"},{"key":"7311_CR3","unstructured":"Milliner DS, Harris PC, Sas DJ et al (2024) Primary hyperoxaluria type 1. In: Adam MP, Feldman J, Mirzaa GM et al, eds. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington; updated Aug 15, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1283"},{"key":"7311_CR4","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/864580","volume":"2011","author":"J Harambat","year":"2011","unstructured":"Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P (2011) Primary hyperoxaluria. Int J Nephrol 2011:864580. https:\/\/doi.org\/10.4061\/2011\/864580","journal-title":"Int J Nephrol"},{"key":"7311_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41581-022-00661-1","volume":"19","author":"JW Groothoff","year":"2023","unstructured":"Groothoff JW, Metry E, Deesker L, Garrelfs S, Acquaviva C, Almardini R et al (2023) Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope. Nat Rev Nephrol 19:194\u2013211. https:\/\/doi.org\/10.1038\/s41581-022-00661-1","journal-title":"Nat Rev Nephrol"},{"key":"7311_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf194","volume":"18","author":"G Mandrile","year":"2025","unstructured":"Mandrile G, Rumsby G, Sciannameo V, Cogal AG, Glover M, Lieske J, Harris PC (2025) Genetic prevalence estimates of primary hyperoxaluria using population databases. Clin Kidney J 18:sfaf194. https:\/\/doi.org\/10.1093\/ckj\/sfaf194","journal-title":"Clin Kidney J"},{"key":"7311_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12687-012-0128-7","volume":"4","author":"N Ben Halim","year":"2013","unstructured":"Ben Halim N, Ben Alaya Bouafif N, Romdhane L, Kefi Ben Atig R, Chouchane I, Bouyacoub Y et al (2013) Consanguinity in Tunisia and its impact on genetic disorders. J Community Genet 4:273\u2013284. https:\/\/doi.org\/10.1007\/s12687-012-0128-7","journal-title":"J Community Genet"},{"key":"7311_CR8","doi-asserted-by":"publisher","unstructured":"M'dimegh S, Omezzine A, M'barek I,\u00a0Moussa A,\u00a0Mabrouk S,\u00a0Kaarout H et al (2017)\u00a0Molecular spectrum of AGXT mutations in Tunisian patients. Ann Hum Genet 81:1\u201310. https:\/\/doi.org\/10.1111\/ahg.12178","DOI":"10.1111\/ahg.12178"},{"key":"7311_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"key":"7311_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","volume":"18","author":"CS van Woerden","year":"2003","unstructured":"van Woerden CS, Groothoff JW, Wanders RJA, Davin JC, Wijburg FA (2003) Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 18:273\u2013279. https:\/\/doi.org\/10.1093\/ndt\/18.2.273","journal-title":"Nephrol Dial Transplant"},{"key":"7311_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/gtmb.2015.0136","volume":"19","author":"L Boualla","year":"2015","unstructured":"Boualla L, Tajir M, Oulahiane N, Lyahyai J, Laarabi ZF, Elalaoui SC et al (2015) AGXT gene mutations and prevalence of primary hyperoxaluria type 1 in Moroccan population. Genet Test Mol Biomarkers 19:623\u2013628. https:\/\/doi.org\/10.1089\/gtmb.2015.0136","journal-title":"Genet Test Mol Biomarkers"},{"key":"7311_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/1319-2442.225202","volume":"29","author":"NR Rhuma","year":"2018","unstructured":"Rhuma NR, Omar A Fituri OA, Sabei LT (2018) Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital. Saudi J Kidney Dis Transpl 29:30\u201338. https:\/\/doi.org\/10.4103\/1319-2442.225202","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"7311_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00996-x","volume":"14","author":"H Murad","year":"2021","unstructured":"Murad H, Alhalabi MB, Dabboul A, Alfakseh N, Nweder MS, Zghib Y, Wannous H (2021) Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1. BMC Med Genomics 14:146. https:\/\/doi.org\/10.1186\/s12920-021-00996-x","journal-title":"BMC Med Genomics"},{"key":"7311_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-04082-8","volume":"20","author":"B Sayed","year":"2025","unstructured":"Sayed B, Alhuthil R, Saadeh S, Al-Shareef T, Alhassoun I, Al-Sabban E (2025) Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center. Orphanet J Rare Dis 20:546. https:\/\/doi.org\/10.1186\/s13023-025-04082-8","journal-title":"Orphanet J Rare Dis"},{"key":"7311_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s004670050143","volume":"10","author":"A Kamoun","year":"1996","unstructured":"Kamoun A, Lakhoua R (1996) End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome. Pediatr Nephrol 10:479\u2013482. https:\/\/doi.org\/10.1007\/s004670050143","journal-title":"Pediatr Nephrol"},{"key":"7311_CR16","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1681\/ASN.2014070698","volume":"26","author":"K Hopp","year":"2015","unstructured":"Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DS, Harris PC (2015) Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol 26:2559\u20132570. https:\/\/doi.org\/10.1681\/ASN.2014070698","journal-title":"J Am Soc Nephrol"},{"key":"7311_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00467-011-1944-3","volume":"27","author":"SM van der Hoeven","year":"2012","unstructured":"van der Hoeven SM, van Woerden CS, Groothoff JW (2012) Delayed diagnosis in primary hyperoxaluria type 1. Pediatr Nephrol 27:89\u201396. https:\/\/doi.org\/10.1007\/s00467-011-1944-3","journal-title":"Pediatr Nephrol"},{"key":"7311_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ndt\/gfad184","volume":"39","author":"PM Ferraro","year":"2024","unstructured":"Ferraro PM, D\u2019Ambrosio V, Gambaro G, Giachino D, Groothoff J, Mandrile G (2024) A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis. Nephrol Dial Transplant 39:367\u2013370. https:\/\/doi.org\/10.1093\/ndt\/gfad184","journal-title":"Nephrol Dial Transplant"},{"key":"7311_CR19","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","volume":"384","author":"SF Garrelfs","year":"2021","unstructured":"Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O\u2019Riordan WD, Cochat P et al (2021) Lumasiran for primary hyperoxaluria type 1. N Engl J Med 384:1216\u20131226. https:\/\/doi.org\/10.1056\/NEJMoa2021712","journal-title":"N Engl J Med"},{"key":"7311_CR20","doi-asserted-by":"publisher","unstructured":"Sas DJ, Magen D, Hayes W, Shasha-Lavsky H, Michael M, Schulte I, ILLUMINATE-B Workgroup et al (2022) Phase 3 trial of lumasiran for primary hyperoxaluria type 1: a new RNAi therapeutic in infants and young children. Genet Med 24:654\u2013662. https:\/\/doi.org\/10.1016\/j.gim.2021.10.024","DOI":"10.1016\/j.gim.2021.10.024"},{"key":"7311_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ekir.2024.10.006","volume":"10","author":"B Hoppe","year":"2024","unstructured":"Hoppe B, Martin-Higueras C, Borghese L, Kaspar S, Reusch B, Beck BB et al (2024) Effective newborn screening for type 1 and 3 primary hyperoxaluria. Kidney Int Rep 10:177\u2013183. https:\/\/doi.org\/10.1016\/j.ekir.2024.10.006","journal-title":"Kidney Int Rep"},{"key":"7311_CR22","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1073\/pnas.1131968100","volume":"100","author":"A Santana","year":"2003","unstructured":"Santana A, Salido E, Torres A, Shapiro LJ (2003) Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc Natl Acad Sci U S A 100:7277\u20137282. https:\/\/doi.org\/10.1073\/pnas.1131968100","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07311-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:06:01Z","timestamp":1785452761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07311-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7311"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07311-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}